questionsmedicales.fr
Environnement et santé publique
Santé publique
Méthodes épidémiologiques
Méthodologie en recherche épidémiologique
Méthode en double aveugle
Méthode en double aveugle : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Méthode en double aveugle : Questions médicales les plus fréquentes",
"headline": "Méthode en double aveugle : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Méthode en double aveugle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-13",
"dateModified": "2025-04-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Méthode en double aveugle"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Méthodologie en recherche épidémiologique",
"url": "https://questionsmedicales.fr/mesh/D015340",
"about": {
"@type": "MedicalCondition",
"name": "Méthodologie en recherche épidémiologique",
"code": {
"@type": "MedicalCode",
"code": "D015340",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N06.850.520.445"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Méthode en double aveugle",
"alternateName": "Double-Blind Method",
"code": {
"@type": "MedicalCode",
"code": "D004311",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hiroyoshi Yajima",
"url": "https://questionsmedicales.fr/author/Hiroyoshi%20Yajima",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Miho Takayama",
"url": "https://questionsmedicales.fr/author/Miho%20Takayama",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Judith M Schlaeger",
"url": "https://questionsmedicales.fr/author/Judith%20M%20Schlaeger",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Nobuari Takakura",
"url": "https://questionsmedicales.fr/author/Nobuari%20Takakura",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Ted J Kaptchuk",
"url": "https://questionsmedicales.fr/author/Ted%20J%20Kaptchuk",
"affiliation": {
"@type": "Organization",
"name": "Program in Placebo Studies, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Automation in ART: Paving the Way for the Future of Infertility Treatment.",
"datePublished": "2022-08-03",
"url": "https://questionsmedicales.fr/article/35922741",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s43032-022-00941-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Automation of duplicate record detection for systematic reviews: Deduplicator.",
"datePublished": "2024-08-02",
"url": "https://questionsmedicales.fr/article/39095913",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13643-024-02619-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Context-Aware Technology Mapping in Genetic Design Automation.",
"datePublished": "2023-01-24",
"url": "https://questionsmedicales.fr/article/36693176",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acssynbio.2c00361"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Automation of Breast Ultrasonography and the Medical Time Dedicated to the Method.",
"datePublished": "2023-08-18",
"url": "https://questionsmedicales.fr/article/37595598",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0043-1772176"
}
},
{
"@type": "ScholarlyArticle",
"name": "Financial Automation Audit Method Based on Blockchain Technology.",
"datePublished": "2022-07-05",
"url": "https://questionsmedicales.fr/article/35837212",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/9941585"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Environnement et santé publique",
"item": "https://questionsmedicales.fr/mesh/D004778"
},
{
"@type": "ListItem",
"position": 3,
"name": "Santé publique",
"item": "https://questionsmedicales.fr/mesh/D011634"
},
{
"@type": "ListItem",
"position": 4,
"name": "Méthodes épidémiologiques",
"item": "https://questionsmedicales.fr/mesh/D004812"
},
{
"@type": "ListItem",
"position": 5,
"name": "Méthodologie en recherche épidémiologique",
"item": "https://questionsmedicales.fr/mesh/D015340"
},
{
"@type": "ListItem",
"position": 6,
"name": "Méthode en double aveugle",
"item": "https://questionsmedicales.fr/mesh/D004311"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Méthode en double aveugle - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Méthode en double aveugle",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Méthode en double aveugle",
"description": "Comment la méthode en double aveugle aide-t-elle au diagnostic ?\nQuels tests utilisent la méthode en double aveugle ?",
"url": "https://questionsmedicales.fr/mesh/D004311?mesh_terms=Automation&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Méthode en double aveugle",
"description": "Les symptômes sont-ils évalués en double aveugle ?\nComment les symptômes sont-ils mesurés en double aveugle ?",
"url": "https://questionsmedicales.fr/mesh/D004311?mesh_terms=Automation&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Méthode en double aveugle",
"description": "La méthode en double aveugle est-elle utilisée en prévention ?\nComment la prévention est-elle testée en double aveugle ?",
"url": "https://questionsmedicales.fr/mesh/D004311?mesh_terms=Automation&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Méthode en double aveugle",
"description": "Quels traitements utilisent souvent la méthode en double aveugle ?\nPourquoi utiliser la méthode en double aveugle pour les traitements ?",
"url": "https://questionsmedicales.fr/mesh/D004311?mesh_terms=Automation&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Méthode en double aveugle",
"description": "Les complications sont-elles prises en compte en double aveugle ?\nComment les complications sont-elles rapportées ?",
"url": "https://questionsmedicales.fr/mesh/D004311?mesh_terms=Automation&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Méthode en double aveugle",
"description": "La méthode en double aveugle évalue-t-elle les facteurs de risque ?\nComment les facteurs de risque sont-ils pris en compte ?",
"url": "https://questionsmedicales.fr/mesh/D004311?mesh_terms=Automation&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment la méthode en double aveugle aide-t-elle au diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet d'évaluer l'efficacité d'un traitement sans biais d'observation."
}
},
{
"@type": "Question",
"name": "Quels tests utilisent la méthode en double aveugle ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des essais cliniques pour tester des médicaments ou des interventions."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils évalués en double aveugle ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, cela permet d'éviter que les attentes influencent les rapports de symptômes."
}
},
{
"@type": "Question",
"name": "Comment les symptômes sont-ils mesurés en double aveugle ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des échelles standardisées, sans que les évaluateurs sachent le traitement reçu."
}
},
{
"@type": "Question",
"name": "La méthode en double aveugle est-elle utilisée en prévention ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, pour évaluer l'efficacité des vaccins ou des interventions préventives."
}
},
{
"@type": "Question",
"name": "Comment la prévention est-elle testée en double aveugle ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "En comparant un groupe recevant le traitement préventif à un groupe placebo."
}
},
{
"@type": "Question",
"name": "Quels traitements utilisent souvent la méthode en double aveugle ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les essais de nouveaux médicaments, thérapies ou interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Pourquoi utiliser la méthode en double aveugle pour les traitements ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pour garantir que les résultats ne soient pas influencés par des attentes ou des biais."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prises en compte en double aveugle ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, pour évaluer les effets indésirables des traitements sans biais."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles rapportées ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des rapports standardisés, sans que les évaluateurs sachent le traitement reçu."
}
},
{
"@type": "Question",
"name": "La méthode en double aveugle évalue-t-elle les facteurs de risque ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, en contrôlant les variables pour isoler l'effet du traitement."
}
},
{
"@type": "Question",
"name": "Comment les facteurs de risque sont-ils pris en compte ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "En randomisant les participants pour équilibrer les caractéristiques entre groupes."
}
}
]
}
]
}
In vitro fertilisation (IVF) is estimated to account for the birth of more than nine million babies worldwide, perhaps making it one of the most intriguing as well as commoditised and industrialised m...
To describe the algorithm and investigate the efficacy of a novel systematic review automation tool "the Deduplicator" to remove duplicate records from a multi-database systematic review search....
We constructed and tested the efficacy of the Deduplicator tool by using 10 previous Cochrane systematic review search results to compare the Deduplicator's 'balanced' algorithm to a semi-manual EndNo...
Before deduplication, the mean library size for the 10 systematic reviews was 1962 records. When using the Deduplicator, the mean time to deduplicate was 5 min per 1000 records compared to 15 min with...
This demonstrates that using the Deduplicator for duplicate record detection reduces the time taken to deduplicate, while maintaining or improving accuracy compared to using a semi-manual EndNote meth...
Genetic design automation (GDA) tools hold promise to speed-up circuit design in synthetic biology. Their widespread adoption is hampered by their limited predictive power, resulting in frequent devia...
In this integrative review, we aimed to describe the records of time devoted by physicians to breast ultrasound in a review of articles in the literature, in order to observe whether the automation of...
Blockchain (BC) maintains a continuously growing database in a "decentralized" way, and its impact on the financial auditing industry is becoming increasingly significant. This paper aims to study the...
Dry eye disease (DED) is a common eye condition worldwide and a primary reason for visits to the ophthalmologist. DED diagnosis is performed through a combination of tests, some of which are unfortuna...
Achieving cost-competitive bio-based processes requires development of stable and selective biocatalysts. Their realization through in vitro enzyme characterization and engineering is mostly low throu...
Older adults with preclinical Alzheimer's disease (AD) show changes in on-road driving performance. The impact of preclinical AD on using automated vehicle (AV) technology is unknown. The aim was to e...
This cross-sectional study included 40 participants: 19 older adults (age 74.16 ± 4.78; MOCA scores 26.42 ± 2.52) with preclinical AD, evidenced by elevated cortical beta-amyloid; and 21 controls (age...
Emergency response times were similar between drivers with preclinical AD and controls in scenario 1 (20.85 s ± 1.08 vs. 20.52 s ± 3.18; p = 0.83) and scenario 2 (14.83 s ± 7.37 vs. 13.45 s ± 10.43; p...
Older drivers with preclinical AD may safely operate AV technology, without increased response times or cognitive workload. Future on-road studies with AV technology should confirm these preliminary r...
Microfluidic capture chips are useful for preparing or analyzing a wide range of different chemical, biological, and medical samples. A typical microfluidic capture chip contains features that capture...
We herein report the development of an automation platform for rapid purification and quantification of chemical libraries including reformatting of chemical matter to 10 mM DMSO stock solutions. This...